Symrise GmbH & Co. KG has entered into a strategic alliance with BRAIN AG and AnalytiCon.
BRAIN AG, a leading industrial biotechnology company, is based in Zwingenberg and develops new bioactive natural compounds as well as proprietary enzymes for the pharmaceutical, food and cosmetic industries.
As part of the planned cooperation, its customized cellular based screening platforms will be made available to Symrise with the goal to identify novel bioactive substances for innovative cosmetics.
The new alliance will allow Symrise to forge into new territory in the development of highly effective cosmetic active ingredients. Achim Daub, a member of the managing board at Symrise, said: “In the growing cosmeceutical market we identified a huge potential for our company following an innovation-oriented product strategy using bioactive natural compounds. The co-operation with the two leading biotech companies BRAIN AG and AnalytiCon Discovery GmbH perfectly supplements and strengthens our own research and development strategies.
“We will further extend this successful strategy and are glad that we managed to build up a strong consortium. together with these two outstanding companies. This strategic partnership also in future will enable us to develop intelligent, natural, bioactive cosmetics with healthy characteristics for our customers.”